These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 7782095)
1. Antiproliferative effect of bone marrow cells on leukemic cells. Seledtsov VI; Avdeev IV; Morenkov AV; Seledtsova GV; Kozlov VA Immunobiology; 1995 Feb; 192(3-4):205-17. PubMed ID: 7782095 [TBL] [Abstract][Full Text] [Related]
2. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study. Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805 [TBL] [Abstract][Full Text] [Related]
3. Bone marrow cells as cytostatic effectors responsible for suppressing leukemia growth in vitro. Seledtsov VI; Avdeev IV; Seledtsova GV; Samarin DM; Prokopenko IV; Kozlov VA Biomed Pharmacother; 1995; 49(6):293-9. PubMed ID: 7579011 [TBL] [Abstract][Full Text] [Related]
4. Graft-versus-leukemia effect using mixed allogeneic bone marrow transplantation. Sykes M; Bukhari Z; Sachs DH Bone Marrow Transplant; 1989 Sep; 4(5):465-74. PubMed ID: 2790325 [TBL] [Abstract][Full Text] [Related]
5. In vitro chemoseparation of leukemic cells from murine bone marrow using VP16-213: importance of stem cell assays. Stiff PJ; Koester AR Exp Hematol; 1987 Mar; 15(3):263-8. PubMed ID: 3545881 [TBL] [Abstract][Full Text] [Related]
6. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts. Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004 [TBL] [Abstract][Full Text] [Related]
7. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice. Afifi MS; Bennett M; Kumar V Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178 [TBL] [Abstract][Full Text] [Related]
8. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells. Dye ES J Immunol; 1986 Feb; 136(4):1510-5. PubMed ID: 3080526 [TBL] [Abstract][Full Text] [Related]
9. The "natural resistance" to bone marrow allografts in normal and athymic nude rats. Rapid cytotoxic reactions both in vivo and in vitro. Rolstad B; Benestad HB Eur J Immunol; 1984 Sep; 14(9):793-9. PubMed ID: 6383840 [TBL] [Abstract][Full Text] [Related]
10. Population dynamics of natural killer cells and T lymphocytes in murine spleen and bone marrow during the development of erythroleukemia: the effect of indomethacin. Miller SC; Christopher FL; Dussault I Nat Immun; 1992; 11(2):78-91. PubMed ID: 1498521 [TBL] [Abstract][Full Text] [Related]
11. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Kiessling R; Klein E; Pross H; Wigzell H Eur J Immunol; 1975 Feb; 5(2):117-21. PubMed ID: 1086218 [TBL] [Abstract][Full Text] [Related]
12. Experimental manipulations and marrow-derived factors which affect the outcome of bone marrow transplantation across the H-2 barrier in lethally irradiated mice. Pierpaoli W; Kellerhals R; Buehler A; Sache E J Clin Lab Immunol; 1985 Mar; 16(3):115-24. PubMed ID: 3897543 [TBL] [Abstract][Full Text] [Related]
13. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines. Rees RC; Reynolds CW; Herberman RB Cancer Res; 1983 Sep; 43(9):4248-52. PubMed ID: 6871862 [TBL] [Abstract][Full Text] [Related]
14. Early B cell precursors in long-term bone marrow culture: selective development in the bone marrow of irradiated recipients. Nishikawa S; Kina T; Amagai T; Katsura Y Eur J Immunol; 1985 Jul; 15(7):696-701. PubMed ID: 3159587 [TBL] [Abstract][Full Text] [Related]
15. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model. Kühl JS; Sikic BI; Blume KG; Chao NJ Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539 [TBL] [Abstract][Full Text] [Related]
16. Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease. Palathumpat V; Dejbakhsh-Jones S; Holm B; Strober S J Immunol; 1992 Aug; 149(3):808-17. PubMed ID: 1386094 [TBL] [Abstract][Full Text] [Related]
17. Peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras abrogates lethal GVHD while preserving GVL effect. de la Selle V; Miconnet I; Gilbert D; Bruley-Rosset M Bone Marrow Transplant; 1995 Jul; 16(1):111-8. PubMed ID: 7581109 [TBL] [Abstract][Full Text] [Related]
18. Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells. Saarloos MN; Khoo NK; Lala PK Cancer Res; 1992 Dec; 52(23):6452-62. PubMed ID: 1423293 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of natural killer cell-mediated lysis of tumor cells by normal and regenerating bone marrow. Miller SC; Galley D; Nguyen DM Immunobiology; 1988 Apr; 177(1):82-90. PubMed ID: 3384448 [TBL] [Abstract][Full Text] [Related]
20. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen. Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]